Literature DB >> 4790578

Renal handling and lymph concentration of two cephalosporin analogues, cephacetrile and cephaloridine: an experimental study in dogs.

K G Naber, P O Madsen.   

Abstract

Cephacetrile (CIBA 36' 278-Ba) and cephaloridine (both cephalosporin derivatives) were compared in dogs with regard to their possible nephrotoxicity, renal handling, and concentration in the renal lymph. No adverse acute effect of either drug on the glomerular filtration rate and effective renal plasma flow was found at very high concentrations in the plasma, with or without concomitant administration of a potent diuretic (furosemide). Cephaloridine was filtered only by the kidney, whereas there was evidence that cephacetrile was also excreted by tubular secretion at low concentrations. The renal lymph concentration of the two antibiotics (in the hilar as well as the capsular lymph vessels) was found to be significantly lower than the simultaneous arterial plasma concentrations. When concentrations in the plasma were high, the relative lymph concentrations of cephaloridine and cephacetrile were in the same range as those of iothalamate (70 to 90% of the arterial plasma level), whereas at low plasma concentrations the lymph concentration of cephacetrile was markedly lower, a finding possibly explained by the active tubular secretion of cephacetrile.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4790578      PMCID: PMC444364          DOI: 10.1128/AAC.3.1.81

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Mechanism of urinary excretion of cephaloridine and its effects on renal function in animals.

Authors:  K J Child; M G Dodds
Journal:  Br J Pharmacol Chemother       Date:  1966-01

2.  Cephaloridine in patients with impaired renal function.

Authors:  M L Dillon; R W Postlewait
Journal:  JAMA       Date:  1971-10-11       Impact factor: 56.272

3.  The nephrotoxicity of cephaloridine.

Authors:  D H Lawson; R F Macadam; H Singh; H Gavras; A L Linton
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

4.  Experimental study of sites of lymph formation in the canine kidney.

Authors:  R D Bell; M J Keyl; W L Parry
Journal:  Invest Urol       Date:  1970-11

5.  Simultaneous determination of glomerular filtration rate and effective plasma flow by external monitoring of radioisotopes. An experimental study in dogs.

Authors:  J F Pedersen; P O Madsen
Journal:  Invest Urol       Date:  1970-09

6.  Composition of canine renal hilar lymph.

Authors:  M J Keyl; J B Scott; J M Dabney; F J Haddy; R B Harvey; R D Bell; H E Ginn
Journal:  Am J Physiol       Date:  1965-11

7.  Effect of angiotensin and of frusemide on plasma aldosterone, corticosterone, cortisol and renin in man.

Authors:  R Fraser; V H James; J J Brown; P Isaac; A F Lever; J I Robertson
Journal:  Lancet       Date:  1965-11-13       Impact factor: 79.321

8.  Toxicity, distribution, and excretion of cephaloridine in laboratory animals.

Authors:  J S Welles; W R Gibson; P N Harris; P M Small; R C Anderson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Nephrotoxicity associated with the use of cephaloridine.

Authors:  A R Hinman; E Wolinsky
Journal:  JAMA       Date:  1967-05-22       Impact factor: 56.272

10.  Distribution of some newer antibiotics within the kidney interstitium: a therapeutic consideration in pyelonephritis.

Authors:  A T Cockett; R S Moore; A P Roberts
Journal:  Invest Urol       Date:  1967-11
View more
  2 in total

1.  Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.

Authors:  S R Westenfelder; K G Naber; P O Madsen
Journal:  Infection       Date:  1973       Impact factor: 3.553

2.  Renal lymph and interstitial fluid concentration of co-trimazine: an experimental study in dogs.

Authors:  S Maigaard; N Frimodt-Möller; K G Naber; P O Madsen
Journal:  Infection       Date:  1979       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.